kresmion.
Pull a receipt

Apimeds Pharmaceuticals US, Inc. (APUS)

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Last price
$2.71
As of

Kresmion compiles this page from APUS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Apimeds Pharmaceuticals US, Inc. (APUS): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-13.

As of . Source: SEC EDGAR filings for APUS. Method and limitations.

COMPANY DOSSIER

See the full APUS dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for APUS on one page. Preview it with sample data, then open it live with a free account.

Preview the APUS dossier

Active events for APUS

No recent events on APUS in the last 180 days.

FREE, NO ACCOUNT

Every event on APUS, as it fires

New filings, 13F moves and cross asset events on APUS land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, APUS

Going concern statement

APUS's 10-Q filed Aug 14, 2026 states:

These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on APUS

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in APUS on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on APUS in the last 180 days.

Upstream: SEC EDGAR filings for APUS

Kresmion, "Apimeds Pharmaceuticals US, Inc. (APUS) institutional holdings and SEC filings", data as of 2026-10-13, https://kresmion.com/research/APUS. Upstream data: SEC EDGAR filings for APUS.

Link to this data (HTML):

<a href="https://kresmion.com/research/APUS">Apimeds Pharmaceuticals US, Inc. (APUS) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow APUS on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to APUS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the APUS dossier
Share

The APUS intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.